Reflective of broader investment concerns around Healius, a single investor has sold a A$74m (US$50.2m) block of shares in the Australian healthcare company. This equates to a 4% share in the group. The shares sold at A$3.00 each, which was a slight discount to its open of A$3.09. The name of the seller has not been…